Condition
Renal Pelvis Carcinoma
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Terminated1
Unknown1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05059444Recruiting
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
NCT05739812Not ApplicableUnknown
The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery
NCT03397394Phase 2Terminated
Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Showing all 3 trials